首页> 美国卫生研究院文献>other >Wakayama Symposium: Peroxisome Proliferator-Activated Receptor-gamma (PPARγ) and Meibomian Gland Dysfunction
【2h】

Wakayama Symposium: Peroxisome Proliferator-Activated Receptor-gamma (PPARγ) and Meibomian Gland Dysfunction

机译:Wakayama研讨会:过氧化物酶促增殖物激活受体-γ(PPARγ)和Meibomian腺体功能障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently we have shown that mouse and human meibomian glands undergo specific age-related changes, including decreased acinar cell proliferation, acinar atrophy, and altered peroxisome proliferator-activated receptor gamma (PPARγ) localization from cytoplasmic-vesicularuclear in young mice and humans to nuclear in old mice and humans. Since PPARγ is a lipid-sensitive, nuclear receptor implicated in regulating adipocyte and sebocyte differentiation and lipogenesis, our findings suggest that PPARγ may be involved in modulating meibomian gland differentiation during aging. Based on these findings, we propose that aging of the meibomian gland results in downregulation of PPARγ, leading to decreased meibocyte differentiation and lipid synthesis, gland atrophy, and a hyposecretory meibomian gland dysfunction.
机译:最近我们发现,小鼠和人类睑板腺经历了与年龄相关的特定变化,包括腺泡细胞增殖减少,腺泡萎缩以及过氧化物酶体增殖物激活受体γ(PPARγ)的定位从幼年小鼠和人类的胞浆-囊泡/核到老老鼠和人类的核。由于PPARγ是脂质敏感的核受体,与调节脂肪细胞和皮脂细胞的分化以及脂肪形成有关,因此我们的发现表明PPARγ可能与衰老过程中调节睑板腺的分化有关。基于这些发现,我们认为睑板腺的衰老会导致PPARγ的下调,导致睑板细胞分化和脂质合成减少,腺体萎缩以及分泌性睑板腺功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号